On Tuesday, Jan. 10, Global Healthcare will become Reuters Health Rounds, a newsletter curated by Nancy Lapid, editor in charge of Reuters Health. Reuters Health Rounds will be sent on Tuesdays and Thursdays.
India has mandated a COVID-19 negative test report for travelers arriving from China, Japan, South Korea, Hong Kong and Thailand, the health minister said on Saturday.
Hong Kong will reopen its borders with mainland China by mid-January, city Chief Executive John Lee said on Saturday, as Beijing accelerates the unwinding of stringent COVID-19 rules that have battered economic growth.
Hungary's government has imposed a windfall tax on drug producers based on net revenues generated in 2022 and 2023, as it tries to plug holes in the state budget.
The consumer information distributed with the emergency contraception now makes clear its mechanism of action does not alter the implantantion of an egg.
The highly-contagious Omicron subvariant XBB has surged to more than 50% of COVID-19 cases in the northeastern United States and risks spreading fast as millions of Americans begin holiday travel on Friday.
The U.S. Food and Drug Administration (FDA) has approved Acer Therapeutics Inc's drug for treating patients with a type of genetic disorder called urea cycle disorders (UCDs), according to the health regulator's website.
An influential drug pricing research group said Eisai Co Ltd and Biogen Inc's new Alzheimer's disease treatment lecanemab should be priced lower than the drug Aduhelm that was developed by the companies.
Nearly 37 million people in China may have been infected with COVID-19 on a single day this week, Bloomberg News reported on Friday, citing estimates from the government's top health authority.
